Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print

Industry News

Related Searches:

Filter by:

November 21, 2007
GlaxoSmithKline has entered an agreement to acquire Reliant Pharmaceuticals Inc. for $1.65 billion in cash. Reliant is a privately held specialty pharma company focused on cardiovascular therapies. In the nine months ending September 30, 2007, the co…   Read More »
November 21, 2007
Covance, Inc. purchased a partially constructed manufacturing facility in Prince William County's Technology Park from Eli Lilly. The company intends to transform the current facility into a 410,000-sq.-ft. state-of-the-art early drug development lab…   Read More »
November 19, 2007
Cook Pharmica has signed an agreement with Inspiration Biopharmaceuticals to conduct development work for its lead biologic therapy, an intravenous Factor IX product for patients with hemophilia B. Activities will be performed in Cook Pharmica's deve…   Read More »
November 19, 2007
Celgene Corp. will acquire Pharmion Corp. for $2.9 billion in a move intended to advance Celgene’s strategy to become a global leader in the hematology/oncology field. The transaction brings together Revlimid, Thalomid and Vidaza, products expe…   Read More »
November 16, 2007
Schering-Plough has received antitrust clearance from the U.S. Federal Trade Commission (FTC) regarding its acquisition of Organon BioSciences from Akzo Nobel. SP received approval from The European Commission on Oct. 11, 2007. Organon BioScience…   Read More »
November 16, 2007
Pfizer has announced that it will spend $164 million to acquire Coley Pharmaceutical Group, a publicly-held biopharmaceutical company specializing in vaccine adjuvant technology and a new class of immunomodulatory drug candidates designed to fight ca…   Read More »
November 15, 2007
GPC Biotech has announced plans to restructure, a process that will include layoffs of approximately 44% of the company’s current active workforce. Both the German and U.S. workforce will be cut. The company is "retaining key personnel nee…   Read More »
November 14, 2007
Azopharma has added a pair of companies to its Azopharma Product Development Group: ApiCross Drug Delivery Technologies and AvivoClin Clinical Services. Based in Hollywood, FL, ApiCross's technology platforms focus on bioavailability enhancement, cus…   Read More »
November 14, 2007
Nastech Pharmaceutical plans to restructure in order to reduce operating expenses. The company will launch a subsidiary, MDRNA, Inc., as an independent, separately financed company, while the main company will concentrate on Phase II clinical and par…   Read More »
November 13, 2007
VaxGen Inc. and Raven biotechnologies have agreed to merge. The merger is expected to create a drug development company with a "robust pipeline of monoclonal antibody candidates in oncology, proprietary antibody discovery platforms, biopharmaceu…   Read More »
November 12, 2007
Advion BioServices, the bioanalytical services division of Advion BioSciences, Inc., will expand its capacity with the recent acquisition of two Applied Biosystems/MDS Sciex API 5000 mass spectrometers and Waters Acquity UPLC capability. In addition,…   Read More »
November 9, 2007
PharmEng International has opened its $15 million pharmaceutical manufacturing facility in Cape Breton, Nova Scotia, Canada. The 46,400-sq.ft. facility, which operates under the name of Keata Pharma, includes offices for PharmEng's pharmaceutical con…   Read More »
November 9, 2007
Merck has agreed to make a $4.85 billion settlement fund to end a vast number of Vioxx lawsuits from U.S. patients. The company stressed that this does not constitute a class-action settlement, but that the fund will cover qualified claims on a case-…   Read More »
November 9, 2007
Catalent Pharma Solutions, has completed the first influenza vaccine manufacturing campaign at its new prefilled syringe manufacturing facility in Neder-Over-Heembeek, Belgium. The production campaign exceeded 21 million prefilled syringes for the…   Read More »
November 7, 2007
Wacker has announced plans to invest $30 million to expand its facility in Jena, Germany. The expansion will cover the GMP production facility as well as the construction of a new building for process development and quality control. "The ne…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On